Use of Human Embryonic Stem Cells (hESCs) in the Treatment of Glaucoma

Shroff, Geeta and Das, Lopamudra (2015) Use of Human Embryonic Stem Cells (hESCs) in the Treatment of Glaucoma. International Journal of Medical and Pharmaceutical Case Reports, 4 (3). pp. 72-76. ISSN 2394109X

[thumbnail of Shroff432015IJMPCR18440.pdf] Text
Shroff432015IJMPCR18440.pdf - Published Version

Download (262kB)

Abstract

Glaucoma is a degenerative, optic neuropathy that results in damage to the optic nerve due to increased intraocular pressure (IOP). IOP can be influenced by hypertension, body mass index, atherosclerotic disease and diabetes. Cell based therapies play an important role in treating eye diseases, especially (irreversible loss of cells) due to glaucoma. We used human embryonic stem cell (hESC) therapy in two patients with glaucoma. hESCs are derived from a patented technology and are in use since the last 13 years. After the therapy, patients showed signs of improvement in their sight such as in peripheral vision, as well as in cognitive abilities like concentration and speech.

Item Type: Article
Subjects: STM Digital > Medical Science
Depositing User: Unnamed user with email support@stmdigital.org
Date Deposited: 16 Jun 2023 09:07
Last Modified: 07 Jun 2024 11:00
URI: http://research.asianarticleeprint.com/id/eprint/1038

Actions (login required)

View Item
View Item